NCT06771622 2026-02-04
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
FBD Biologics Limited
Phase 1/2 Active not recruiting
Clinical Trials
12 trialsNCT07242417 2026-01-21
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
Beijing GoBroad Hospital
Phase EARLY_PHASE1 Recruiting
NCT07301996 2025-12-24
Mobile PRO
Asan Medical Center
Phase NA Completed
NCT07281326 2025-12-15
A Study of AK138D1 in Advanced Malignant Tumors
Akeso
Phase 1 Recruiting
NCT07051161 2025-07-04
ENDoRA
University Hospital, Grenoble
Not yet recruiting
NCT06797037 2025-05-20
Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)
Institut Claudius Regaud
Phase NA Recruiting
NCT06894082 2025-03-25
Cimer
Institut Paoli-Calmettes
Recruiting
NCT06730386 2025-03-06
A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
Akeso
Phase 1 Recruiting
NCT06697665 2024-11-20
An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Recruiting
NCT03721679 2021-02-01
Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
Oncovir, Inc.
Phase 1/2 Terminated
NCT03311100 2018-01-30
Immunological Profile of Solid Tumors Sample
Assistance Publique Hopitaux De Marseille
Unknown
NCT00925743 2013-05-16
A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer
Sanofi
Phase 1 Completed